SCHEMBL4127705

SCHEMBL4127705

COc1cccc(C(O)c2cc(Cl)cc(F)c2NC(=O)OC(C)(C)C)c1OC

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 4/20 0.38
LPAR1 Q92633 1/20 0.36
ATR Q13535 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
S1PR3 Q99500 1/20 0.35
MAPT P10636 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BCHE P06276 1/20 0.34
POLB P06746 1/20 0.34
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4110496 0.91 FDFT1 (0.40) FDFT1LPAR1ATRMAPTALDH1A1
SCHEMBL4119083 0.87 ALDH1A1 (0.39) FDFT1LPAR1MEN1KMT2AATM
SCHEMBL13776019 0.83 LPAR1 (0.45) FDFT1LPAR1MEN1KMT2AMAPT
SCHEMBL13775927 0.82 KDM4E (0.39) FDFT1MEN1KMT2AMAPTALDH1A1
SCHEMBL13776116 0.80 LMNA (0.41) FDFT1MEN1KMT2AS1PR3MAPT
SCHEMBL4124330 0.78 LPAR1 (0.40) FDFT1LPAR1S1PR3ALDH1A1POLB
SCHEMBL13775916 0.77 LMNA (0.51) FDFT1MEN1KMT2AMAPTALDH1A1
SCHEMBL13775845 0.77 LPAR1 (0.41) FDFT1LPAR1MEN1KMT2AMAPT
SCHEMBL13775919 0.77 LMNA (0.40) FDFT1MEN1KMT2AMAPTALDH1A1
SCHEMBL4124464 0.77 LPAR1 (0.43) FDFT1LPAR1MEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
US-20090181942-A1 TRICYCLIC COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-07-16 US disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed
EP-1939205-A1 TRICYCLIC COMPOUND Daiichi Sankyo Company, Limited (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181942-A1 TRICYCLIC COMPOUNDS FDFT1, COASY, HMGCR FDFT1 1/4885LPAR1 345/4885ATR 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.